跳至主要内容
临床试验/CTRI/2009/091/000456
CTRI/2009/091/000456已完成3 期

A multicentric, single blind, parallel, randomized, phase-III study to evaluate the immunogenicity & safety of BEs combined pentavalent DTwP-rHepB-HIB liquid vaccine administered to 6-8 week old healthy Indian subjects at 6-10-14 weeks EPI schedule in comparison with marketed Shan5 vaccine. - None

Biological E Limited Azamabad Hyderabad AP India0 个研究点目标入组 90 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Intended subjects will be healthy infants between 6 to8 weeks of age that is 42 to 56 days of age,both days inclusive of either gender at the time of 1st vaccination.
  • 2.Written informed consent obtained from the subjectâ??s parents or legal representative or guardian.
  • 3.Healthy infants with weight greater than or equal to 3300 gms at the time of screening.
  • 4.Good clinical condition established by medical history and physical examination with no acute disease, infection or high temperature that is greater then 38.5 degrees C axillary temperature.
  • 5.Healthy infants born to mothers seronegative to HBV and HIV as confirmed by laboratory tests on the mother or based on maternity discharge summary.
  • 6.Subjects or their mothers not participating in any other trials.
  • 7.Infants without contraindications or precautionary circumstances for participating in the trial
  • 8.Ability of the subjectâ??s parent or legal representative or guardian to understand and comply with the requirements of the protocol.

排除标准

  • Prior immunization with DTP, Hepatitis-B or HIB vaccine with the exception of BCG &/or oral polio vaccine; Current illness (especially fever) or any acute or congenital illness or disability; Known or suspected allergy to any of the vaccine components; Any sign or symptom or systemic dysfunction, especially of the central nervous system (CNS); Known family history of SIDS (Sudden Infant Death Syndrome); Inability or unwillingness to abide by the requirements of the protocol; Any criteria, which in the opinion of the Investigator, suggests that the subject would not be compliant with the study protocol.

研究者

发起方
Biological E Limited Azamabad Hyderabad AP India

相似试验